MA
MIRO

MYDA Advisors’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

MYDA Advisors’s Portfolio MIRO Stock Details MIRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-30,000
Closed -$350K – 320
2021
Q2 		$350K Buy
+30,000
New +$386K 0.09% 218

Other funds holding MIRO

GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return

MYDA Advisors's MIRO Position: Q3 2021 in Review

MYDA Advisors sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q3 2021, closing a stake of 30,000 shares — an estimated $350K sold.

MYDA Advisors first reported a position in MIRO in Q2 2021 and held it in 1 quarter. The position peaked at $350K in Q2 2021. 19 funds tracked by Wall St. Rank hold MIRO as of Q3 2021.

  • MYDA Advisors reported no remaining Miromatrix Medical Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • MYDA Advisors sold 30,000 Miromatrix Medical Inc. Common Stock shares in Q3 2021, an estimated $350K.
  • MYDA Advisors first reported a position in Miromatrix Medical Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • MYDA Advisors's Miromatrix Medical Inc. Common Stock position peaked at $350K in Q2 2021.
  • 19 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q3 2021.

Based on MYDA Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.